We trace DDB’s historic creative impact, its partnership with Mudra, and how the brand’s recent retirement reframes the ...
What started as a childhood fascination with science and sport has grown into a mission to "democratise" technology with innovative, affordable rehabilitation solutions for people with limited ...
ImmunityBio delivered strong 3Q25 results, with Anktiva driving 434% YoY product revenue growth and a narrowed operating loss ...
Study Finds on MSN
Woodpeckers Use Tennis Player ‘Grunting’ Trick To Drill Trees
In A Nutshell Woodpeckers exhale forcefully with every peck, using the same “grunting” technique tennis players use to boost their serve power They take miniature breaths lasting just 40 milliseconds ...
Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple ...
The Therabody Theragun Pro Plus is a powerful, feature-rich massage gun, which we’d recommend for physical therapists, ...
Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.
A regimen of three immune-suppressing drugs may improve the effectiveness of gene therapy for people with DMD, research in ...
Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.
The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.
A research team has found that specific immune cells can connect with muscle fibers in a lightning-fast, neuron-like way to ...
Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback